Drug:
Reaction: MYELOSUPPRESSION
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26524474 |
69 | 1 | |
Myelosuppression, Platelet count decreased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 202 | 26524689 |
CN |
32 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, Dizziness, Gingival bleeding, Epistaxis, Pyrexia, Infection, |
||||
CYTARABINE, METHOTREXATE SODIUM, |
||||
| 203 | 26524724 |
CN |
12 | 1 |
Myelosuppression, Hyperpyrexia, Gingival bleeding, Epistaxis, Gingival swelling, |
||||
CYTARABINE, |
||||
| 204 | 26524866 |
CN |
58 | 2 |
Platelet count decreased, White blood cell count decreased, Neutrophil count decreased, Myelosuppression, |
||||
BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 205 | 26524903 |
CN |
64 | 1 |
Myelosuppression, |
||||
RAMUCIRUMAB, OXALIPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 206 | 26525335 |
55 | 2 | |
Myelosuppression, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 207 | 26525631 |
EU |
66 | 2 |
Myelosuppression, Hepatic steatosis, Therapy cessation, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, |
||||
| 208 | 26525715 |
CN |
78 | 1 |
Cytokine release syndrome, Myelosuppression, Rash, Erythema, Platelet count decreased, |
||||
BORTEZOMIB, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, LENALIDOMIDE, |
||||
| 209 | 26526199 |
JP |
2 | |
Myelosuppression, |
||||
OLAPARIB, DURVALUMAB, |
||||
| 210 | 26526546 |
JP |
39 | 1 |
Myelosuppression, Neutrophil count decreased, |
||||
DURVALUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
| 211 | 26526601 |
CN |
69 | 1 |
Myelosuppression, Pyrexia, Procalcitonin increased, Neutrophil percentage increased, C-reactive protein increased, |
||||
CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 212 | 26526602 |
CN |
81 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 213 | 26526607 |
CN |
69 | 1 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 214 | 26526608 |
CN |
53 | 1 |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 215 | 26526612 |
CN |
71 | 2 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, CARBOPLATIN, |
||||
| 216 | 26526641 |
CN |
74 | 1 |
Myelosuppression, |
||||
| 217 | 26526652 |
CN |
51 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, |
||||
| 218 | 26526653 |
CN |
53 | 1 |
Myelosuppression, Hypoaesthesia, |
||||
OXALIPLATIN, OXALIPLATIN, CAPECITABINE, |
||||
| 219 | 26526685 |
CN |
52 | 2 |
Myelosuppression, |
||||
CAPECITABINE, CAPECITABINE, OXALIPLATIN, OXALIPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 220 | 26526701 |
CN |
56 | 2 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 221 | 26526706 |
CN |
67 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 222 | 26521136 |
CN |
88 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 223 | 26521193 |
CN |
64 | 1 |
White blood cell count decreased, Neutrophil count decreased, Myelosuppression, |
||||
TRASTUZUMAB, NIVOLUMAB, |
||||
| 224 | 26521281 |
CN |
47 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 225 | 26516909 |
CN |
67 | 1 |
Myelosuppression, |
||||
BEVACIZUMAB, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 226 | 26516979 |
CN |
66 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 227 | 26517012 |
CN |
54 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 228 | 26517020 |
CN |
54 | 2 |
Myelosuppression, Neutrophil count decreased, White blood cell count decreased, Mean cell haemoglobin concentration decreased, Neutrophil percentage decreased, Nausea, Abdominal discomfort, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, EPIRUBICIN HYDROCHLORIDE, |
||||
| 229 | 26517021 |
CN |
41 | 2 |
Myelosuppression, Monocyte count decreased, White blood cell count decreased, Haemoglobin decreased, Mean cell haemoglobin concentration decreased, Neutrophil percentage decreased, Neutrophil count decreased, Lymphocyte count decreased, Discomfort, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 230 | 26517055 |
CN |
51 | 1 |
Drug intolerance, Fatigue, Myelosuppression, Alopecia, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 231 | 26517374 |
CN |
68 | 2 |
Myelosuppression, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, BEVACIZUMAB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 232 | 26517376 |
CN |
62 | 1 |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 233 | 26517377 |
CN |
56 | 2 |
Myelosuppression, Underdose, |
||||
DENOSUMAB, DENOSUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, |
||||
| 234 | 26517378 |
CN |
69 | 2 |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 235 | 26517379 |
CN |
65 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 236 | 26517382 |
CN |
58 | 1 |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 237 | 26517601 |
CN |
62 | 2 |
Liver injury, Myelosuppression, |
||||
STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 238 | 26517678 |
CN |
41 | 2 |
Myelosuppression, |
||||
DARATUMUMAB, APREPITANT, |
||||
| 239 | 26518044 |
CN |
76 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 240 | 26518079 |
CN |
57 | 1 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, EPIRUBICIN HYDROCHLORIDE, VINCRISTINE SULFATE, |
||||
| 241 | 26518080 |
CN |
55 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, VINCRISTINE SULFATE, |
||||
| 242 | 26518101 |
CN |
70 | 2 |
Aspergillus infection, Influenza, Thrombocytopenia, Leukopenia, Myelosuppression, Pneumonia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, RITUXIMAB, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, |
||||
| 243 | 26518381 |
CN |
72 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, CAPECITABINE, TRASTUZUMAB, |
||||
| 244 | 26518477 |
CN |
2 | |
Myelosuppression, |
||||
PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
| 245 | 26519258 |
CN |
||
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 246 | 26519260 |
CN |
||
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 247 | 26519265 |
CN |
||
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 248 | 26519267 |
CN |
68 | 2 |
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 249 | 26519271 |
CN |
||
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 250 | 26519272 |
CN |
||
Myelosuppression, Therapeutic product effect incomplete, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 251 | 26519274 |
CN |
64 | 1 |
Myelosuppression, Therapeutic product effect incomplete, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 252 | 26519382 |
CN |
78 | 1 |
Cytokine release syndrome, Myelosuppression, Rash, Erythema, Platelet count decreased, |
||||
DARATUMUMAB, DARATUMUMAB, BORTEZOMIB, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, LENALIDOMIDE, |
||||
| 253 | 26519557 |
CN |
63 | 1 |
Shock haemorrhagic, Respiratory failure, Myelosuppression, Pneumonia, Eye haemorrhage, Mouth haemorrhage, Pharyngeal haematoma, Staphylococcal infection, |
||||
CYTARABINE, CYTARABINE, ETOPOSIDE, DECITABINE, VENETOCLAX, |
||||
| 254 | 26519574 |
CN |
||
Myelosuppression, Therapeutic product effect incomplete, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 255 | 26519588 |
CN |
79 | 1 |
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 256 | 26519589 |
CN |
||
Myelosuppression, Pancytopenia, Drug interaction, Hyponatraemia, |
||||
LINEZOLID, LINEZOLID, DAPAGLIFLOZIN, METOPROLOL TARTRATE, METOPROLOL, TORSEMIDE, VALSARTAN, VALSARTAN ORAL, |
||||
| 257 | 26519591 |
CN |
||
Myelosuppression, Pancytopenia, Drug interaction, |
||||
LINEZOLID, DAPAGLIFLOZIN, BUDESONIDE, INSULIN ASPART, INSULIN DEGLUDEC, |
||||
| 258 | 26519601 |
CN |
72 | 1 |
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 259 | 26519607 |
CN |
||
Myelosuppression, Infection, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 260 | 26519632 |
CN |
74 | 1 |
Myelosuppression, Platelet count decreased, Pyrexia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, CYTARABINE, |
||||
| 261 | 26519783 |
CN |
70 | 2 |
Myelosuppression, Leukopenia, Pneumonia, Aspergillus infection, Influenza, Acute respiratory failure, Diffuse large B-cell lymphoma refractory, Thrombocytopenia, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, POLATUZUMAB VEDOTIN, PREDNISONE, RITUXIMAB, BENDAMUSTINE HCL, |
||||
| 262 | 26520467 |
CN |
34 | 1 |
Full blood count decreased, Myelosuppression, Oxygen saturation decreased, Infection, Off label use, |
||||
CYTARABINE, ETOPOSIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 263 | 26520586 |
JP |
8 | 1 |
Myelosuppression, Febrile neutropenia, Aortic dissection, |
||||
TRIFLURIDINE AND TIPIRACIL, BEVACIZUMAB, |
||||
| 264 | 26512294 |
CN |
55 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 265 | 26512356 |
CN |
69 | 1 |
Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, BEVACIZUMAB, |
||||
| 266 | 26512428 |
US |
2 | 2 |
Drug ineffective, Photosensitivity reaction, Myelosuppression, |
||||
RIFAMPIN, RIFAMPIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, RIFABUTIN, RIFABUTIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 267 | 26512441 |
CN |
65 | 1 |
Myelosuppression, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 268 | 26512457 |
CN |
73 | 1 |
Myelosuppression, |
||||
| 269 | 26512459 |
CN |
58 | 1 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 270 | 26512669 |
CN |
55 | 2 |
White blood cell count decreased, Myelosuppression, |
||||
| 271 | 26513076 |
CN |
67 | 1 |
Diarrhoea, Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED DISODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 272 | 26513121 |
CN |
2 | |
Myelosuppression, |
||||
BEVACIZUMAB, BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, |
||||
| 273 | 26513145 |
CN |
62 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 274 | 26513345 |
CN |
41 | 2 |
Myelosuppression, Product use in unapproved indication, Acute myeloid leukaemia, |
||||
APREPITANT, DARATUMUMAB, |
||||
| 275 | 26513369 |
CN |
67 | 2 |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 276 | 26513836 |
US |
2 | 2 |
Drug ineffective for unapproved indication, Myelosuppression, Product prescribing issue, |
||||
RIFAMPIN, RIFAMPIN, RIFAMPIN, RIFAMPIN, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, RIFABUTIN, RIFABUTIN, RIFABUTIN, RIFABUTIN, RIFABUTIN, RIFABUTIN, RIFABUTIN, RIFABUTIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 277 | 26514988 |
CN |
41 | 2 |
Myelosuppression, |
||||
EXEMESTANE, RIBOCICLIB, |
||||
| 278 | 26514991 |
CN |
38 | 2 |
White blood cell count decreased, Neutrophil count decreased, Myelosuppression, Febrile neutropenia, Pain, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 279 | 26515884 |
CA |
1 | |
Thrombocytopenia, Myelosuppression, |
||||
DURVALUMAB, |
||||
| 280 | 26516432 |
CN |
57 | 1 |
Myelosuppression, Pyrexia, Neutropenia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, |
||||
| 281 | 26516433 |
CN |
71 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, |
||||
| 282 | 26507721 |
CN |
55 | 1 |
Myelosuppression, |
||||
DENOSUMAB, |
||||
| 283 | 26507936 |
CN |
56 | 2 |
Myelosuppression, |
||||
DENOSUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 284 | 26508226 |
MX |
||
Neuropathy peripheral, Myelosuppression, Hepatotoxicity, Nephropathy toxic, Electrocardiogram QT prolonged, Mental disorder, Skin reaction, |
||||
BEDAQUILINE FUMARATE, BEDAQUILINE FUMARATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, CYCLOSERINE, CYCLOSERINE, LINEZOLID, LINEZOLID, |
||||
| 285 | 26508236 |
CN |
43 | 2 |
Disease progression, Epilepsy, Confusional state, Myelosuppression, |
||||
GLOFITAMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ZANUBRUTINIB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, |
||||
| 286 | 26508415 |
CN |
||
Nausea, Vomiting, Liver injury, Myelosuppression, Thrombocytopenia, Leukopenia, Renal injury, |
||||
CAPECITABINE, TRASTUZUMAB, TRASTUZUMAB, OXALIPLATIN, |
||||
| 287 | 26508735 |
CN |
38 | 2 |
White blood cell count decreased, Myelosuppression, C-reactive protein increased, |
||||
| 288 | 26508741 |
CN |
72 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, OXALIPLATIN, |
||||
| 289 | 26508749 |
CN |
32 | 2 |
Myelosuppression, Neutrophil count decreased, Haemoglobin decreased, |
||||
VENETOCLAX, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 290 | 26508791 |
22 | 2 | |
Myelosuppression, |
||||
| 291 | 26508827 |
56 | 2 | |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 292 | 26508837 |
37 | 2 | |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 293 | 26508839 |
CN |
61 | 2 |
Myelosuppression, |
||||
ZOLBETUXIMAB, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, |
||||
| 294 | 26508864 |
31 | 2 | |
Myelosuppression, |
||||
| 295 | 26509039 |
CN |
70 | 1 |
Myelosuppression, Drug-induced liver injury, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 296 | 26509613 |
CN |
42 | 1 |
Myelosuppression, |
||||
CARFILZOMIB, DENOSUMAB, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 297 | 26509737 |
AU |
64 | 2 |
Myelosuppression, Radiotherapy, Blood thyroid stimulating hormone decreased, Diarrhoea, Liver function test abnormal, Thyroxine free increased, |
||||
PEGFILGRASTIM, CARBOPLATIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PEMBROLIZUMAB, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 298 | 26511307 |
CN |
60 | 2 |
Myelosuppression, |
||||
| 299 | 26511457 |
JP |
44 | 2 |
Febrile neutropenia, Myelosuppression, |
||||
| 300 | 26511965 |
CN |
52 | 2 |
Myelosuppression, |
||||
ABEMACICLIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28